Updated on 10 September 2026
Thermo-electric cooling/heating devices: (1.) Human Wearables; (2.) Robots; (3.) GPU's
Deputy CEO at CNI Securities Group
China (Hong Kong)
About
The product is first to world market and is a blockbuster project with very strong ESG applications. In an age of global warming and health hazards human wearables are the future of the U.S.$500 billon functional clothing segment.
Project Location
- China
Project Format
- Private Project
Go Global Project
- Yes
ESG (Environmental, Social, and Governance)
- Yes
Project Stage
- Investment / Financing Discussion
Main Project Sector
- Manufacturing
- Technology
Technology
- Environmental Technology
- Health Technology
Total Project Value
- 50,000,001 USD or above
Investment Capital Required
- 5,000,001 to 7,500,000 USD
Interested Format of Cooperation
- Direct Equity Investment
Preferred Financing Model
- Equity
Type(s) of Last Financing Round of the project (if Applicable)
- Venture Capital (VC)
Main Service(s) Required
- Financial Services
Financial Services
- Institutional Investment
Attached files
Organisation
China
Similar opportunities
Project
A First-in-Class Antivirulence Drug for the Treatment of Eczema (Atopic Dermatitis)
- No
- Yes
- Equity
- Bio-Tech
- Technology
- Private Project
- Equity (private)
- Professional Services
- Minority Shareholdings
- 50,000,001 USD or above
- Direct Equity Investment
- 5,000,001 to 7,500,000 USD
- Risk Management & Resilience
- Private Equity & Venture Capital
- Investment / Financing Discussion
Thomas Lee
Chief Operating Officer at Antenovus Biotechnology Limited
China (Hong Kong)
Project
- Yes
- Yes
- Equity
- Bio-Tech
- Technology
- Private Project
- Health Technology
- Equity (private)
- Medical Technology
- Financial Services
- Direct Equity Investment
- 5,000,001 to 7,500,000 USD
- 25,000,001 to 50,000,000 USD
- Investment / Financing Discussion
Roger Zhang
Commercial Director at Centre for Virology, Vaccinology and Therapeutics Limited
China (Hong Kong)
Project
CODI - Robot-Assisted Echocardiography
- Yes
- Yes
- Equity
- Technology
- Private Project
- Health Technology
- Medical Technology
- Financial Services
- Investment Banking
- Venture Capital (VC)
- Minority Shareholdings
- Direct Equity Investment
- 10,000,001 to 25,000,000 USD
- 10,000,001 to 25,000,000 USD
- Private Equity & Venture Capital
- Investment / Financing Discussion
Matthew Sefati
CEO at Cobionix
Canada